SCHEMBL16331435

SCHEMBL16331435

Cn1c(-c2cccc(Cl)c2)cc2c(Nc3ccncn3)nccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FYN P06241 4/20 0.49
▸ MAP4K4 O95819 3/20 0.40
▸ MKNK2 Q9HBH9 1/20 0.39
▸ JAK2 O60674 2/20 0.39
▸ TYK2 P29597 2/20 0.39
▸ MPL P40238 1/20 0.38
▸ IDO1 P14902 1/20 0.38
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ CCNA2 P20248 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ CCNA1 P78396 1/20 0.37
▸ CDC7 O00311 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ JAK1 P23458 1/20 0.35
▸ TGFBR1 P36897 1/20 0.35
▸ TGFBR2 P37173 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16331663 0.80 FYN (0.41) FYNMKNK2JAK2TYK2CYP1A2
SCHEMBL16332442 0.80 FYN (0.41) FYNCYP1A2CYP2C9CYP3A4CYP2C19
SCHEMBL31735781 0.78 FYN (0.51) FYNJAK2TYK2CCNA2CDK2
SCHEMBL16331769 0.75 HPGD (0.43) FYNCYP1A2CYP2C9CYP3A4CYP2C19
SCHEMBL8346915 0.69 MPL (0.49) FYNMAP4K4JAK2TYK2MPL
SCHEMBL16332400 0.67 CTSC (0.42) FYNCYP1A2CYP2C9CYP3A4CYP2C19
SCHEMBL2383798 0.67 JAK2 (0.57) JAK2TYK2CYP1A2CYP2C9CYP3A4
SCHEMBL16332706 0.67 CNR2 (0.47) FYNCYP1A2CYP3A4CYP2C19CDK2
SCHEMBL16331628 0.67 HPGD (0.50) CYP1A2CYP3A4CDC7HSD17B10
SCHEMBL31735626 0.67 FYN (0.44) FYNMAP4K4KDRTGFBR1TGFBR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458463-B2 Method for treatment of diabetes by a small molecule inhibitor for GRK5 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2016-10-04 — — US claimed
EP-2818472-A1 Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-12-31 — — EP claimed
EP-2818472-A1 Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-12-31 — — EP disclosed
Send feedback